Physician

Syed Amal Hussnain, MD

According to 2025 Medicare claims, Syed Hussnain, MD (NPI: 1285072769) practices ophthalmology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is SARATOGA VITREO-RETINAL OPHTHALMOLOGY, PLLC (NPI: 1316055940; TIN: 208260244) and primary practice location at 12020-4105. Hussnain is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Hussnain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 455 traditional Medicare patients, billed 12,348 HCPCS/CPT codes, and received $1,348,406 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 384 prescription claims across 108 beneficiaries totaling $28,261 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 4 records totaling $247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,144 to $1,348,406. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $4,283 to $28,261. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$674K$1.3M2018 Medicare payment: $4,144 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $255,088 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $903,747 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $890,354 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $977,577 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,028,029 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,348,406 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181728$4,144
20193081,608$255,088
20203955,137$903,747
20214245,138$890,354
20224344,673$977,577
20234465,349$1,028,029
202445512,348$1,348,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$29K2015 Drug cost: $4,283 (USD; Tot_Drug_Cst)2016 Drug cost: $7,196 (USD; Tot_Drug_Cst)2018 Drug cost: $4,399 (USD; Tot_Drug_Cst)2019 Drug cost: $7,593 (USD; Tot_Drug_Cst)2020 Drug cost: $24,566 (USD; Tot_Drug_Cst)2021 Drug cost: $22,787 (USD; Tot_Drug_Cst)2022 Drug cost: $27,615 (USD; Tot_Drug_Cst)2023 Drug cost: $28,763 (USD; Tot_Drug_Cst)2024 Drug cost: $28,261 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152552$4,283
20162052$7,196
2017N/RN/RN/R
20182860$4,399
20193790$7,593
202068206$24,566
202183220$22,787
202289255$27,615
202390316$28,763
2024108384$28,261

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1241,357$655
92014Established patient complete exam of visual system396818$88
67028Injection of drug into eye1861,135$81
J9035Injection, bevacizumab, 10 mg80332$55
92134Imaging of retina4471,668$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium761,412$9,209
DifluprednateDifluprednate571,319$8,096
Prednisolone AcetatePrednisolone Acetate571,904$2,766
Ketorolac TromethamineKetorolac Tromethamine301,178$949
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha541,037$641

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$247Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Syed Amal Hussnain, MD?

Tedicare shows public-source Medicare data for Syed Amal Hussnain, MD (NPI 1285072769), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Syed Amal Hussnain, MD have ACO affiliation data?

Syed Amal Hussnain, MD is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Syed Amal Hussnain, MD?

Syed Amal Hussnain, MD is linked to SARATOGA VITREO-RETINAL OPHTHALMOLOGY, PLLC (billing NPI 1316055940) in the available physician profile data.

Does Syed Amal Hussnain, MD have Open Payments data?

Syed Amal Hussnain, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.